Cancer Treatment-Related Radiodermatitis
Patient Guideline Summary
Publication Date: November 1, 2020
Last Updated: March 2, 2023
Objective
Objective
This patient summary means to discuss key recommendations from the Oncology Nursing Forum for cancer treatment-related radiodermatitis.
Overview
Overview
- Radiodermatitis is an inflammation of the skin due to radiation (x-ray) treatment for cancer.
- Symptoms include pain and skin damage.
- The severity of the damage varies with the dose of radiation.
- This patient summary focuses on management of radiodermatitis.
Treatment
Treatment
- Deodorant/antiperspirant
- Topical steroids (cortisone applied to the skin) (prescription strength preferred)
- Standard washing/skincare before and after treatment
- Only in a clinical trial: aloe vera and oral curcumin
- Not recommended: emu oil, calendula, nonsteroidal interventions
Source Citation
Gosselin, T., Ginex, P., Backler, C., Bruce, S., Hutton, A., Marquez, C., McGee, L., Shaftic, A. M., Suarez, L., Moriarty, K., Maloney, C., Vrabel, M., & Morgan, R. (2020). ONS GuidelinesTM for Cancer Treatment–Related Radiodermatitis. Oncology Nursing Forum, 47(6), 654–670. https://doi.org/10.1188/20.onf.654-670
Disclaimer
The information in this patient summary should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.